The global contraceptive market is estimated to grow at 4.3% during 2015-2022 and is estimated to be $32.85 billion by 2022. Increasing prevalence of sexually transmitted diseases and growing need for population control. The global contraceptive market is majorly driven by various factors such as growing prevalence of sexually transmitted infections (STIs), such as HIV. The introduction of new products, exhibiting improved efficacy are expected to drive the contraceptive market over the forecast period.
The global ophthalmic drugs market is expected to grow at a CAGR of 7% during 2015-2022 and is estimated to be approximately $XX billion at the end of the forecasted period i.e. by 2022. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure in emerging countries such as India and China.
The global pharmaceuticals market has been consistent of large companies based in US and Europe. The pharma market is a challenging one and is constantly evolving to meeting the healthcare needs of a growing population. While generic drugs have dominated the market in developing countries the demand for the latest drug discoveries and better healthcare is increasing demand in these countries. The pharmaceutical industry has seen high level of mergers and acquisition which are helping it grow in a rationalized fashion.
Our reports help identify key industry statistics and trends. Brisk Insights focuses on important performance geographies and competitive analysis.